名家匯(300506.SZ)擬對名匠智匯及大話神遊分別減少註冊資本3000萬元及3200萬元
格隆匯 12 月 18日丨名家匯(300506.SZ)公佈,公司於2020年12月18日召開了公司第三屆董事會第三十二次會議、第三屆監事會第二十六次會議,分別審議通過了《關於對全資子公司減少註冊資本的議案》,同意公司對全資子公司名匠智匯建設發展有限公司(“名匠智匯”)和北京大話神遊光影科技發展有限公司(“大話神遊”)分別減少註冊資本3000萬元、3200萬元。
此次減資完成後,名匠智匯的註冊資本將由5000萬元變更為2000萬元,大話神遊的註冊資本將由5000萬元變更為1800萬元,公司仍持有名匠智匯和大話神遊100%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.